$8.03B | |
$332.74 | |
$914.26 | |
$11.85 | |
$332.92 | |
$-15.59 | |
-4.68% | |
332K |
Praxis Precision Medicines, Inc. (PRAX) is currently trading at $318.62 as of 2026-02-13 20:56:34, reflecting a -4.68% move ($-15.59) from the previous close.
In the short term, the stock has returned +701.12% over the past four weeks. Over the last 12 months, Praxis Precision Medicines, Inc. has recorded a +267.66% price change, indicating a strong performance relative to the broader market.
Over the past seven days, Praxis Precision Medicines, Inc. has traded within a short-term range shaped by market sentiment in the PHARMACEUTICAL PREPARATIONS sector. During this period, the stock moved from its previous closing price of $317.73 to the latest recorded price of $318.62, reflecting an intraday change of -4.68%. Daily movements highlight shifts in trading volume (332,163), investor positioning, and reactions to macroeconomic updates.
From a momentum standpoint, PRAX has delivered a +701.12% return over the past month and a +267.66% change in the last 12 months, indicating a strong trend relative to its broader sector peers.
You can buy and trade PRAX on MEXC in three simple steps:
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 10,998 |
| Sector | PHARMACEUTICAL PREPARATIONS |
| Company Website |
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Amount
1 PRAX = 318.615 USD